SCHEMBL10114568

SCHEMBL10114568

CC(=O)Oc1ccc(C(=O)Nc2ncc(S(C)(=O)=O)s2)cc1I

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.44
SMN1; SMN2 Q16637 6/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
HTT P42858 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RAB9A P51151 8/20 0.40
NPC1 O15118 6/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
PAX8 Q06710 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PKM P14618 3/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPK1 P28482 2/20 0.40
MAPT P10636 2/20 0.40
MLNR O43193 1/20 0.40
NR1I2 O75469 1/20 0.40
ABCB11 O95342 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757209 0.83 MEN1 (0.46) SMN1; SMN2MEN1KMT2AHTTL3MBTL1
SCHEMBL702024 0.82 RAB9A (0.57) SMN1; SMN2MEN1KMT2AHTTRAB9A
SCHEMBL703471 0.81 MEN1 (0.51) SMN1; SMN2MEN1KMT2AHTTL3MBTL1
SCHEMBL10114373 0.80 GCK (0.40) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL10114651 0.79 ALDH1A1 (0.46) TOP1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL705921 0.78 ALDH1A1 (0.64) SMN1; SMN2MEN1KMT2AHTTL3MBTL1
SCHEMBL4937296 0.76 TOP1 (0.46) TOP1SMN1; SMN2MEN1KMT2AHTT
SCHEMBL4756248 0.76 MEN1 (0.43) SMN1; SMN2MEN1KMT2AHTTL3MBTL1
SCHEMBL4756236 0.76 RAB9A (0.44) SMN1; SMN2MEN1KMT2AHTTL3MBTL1
SCHEMBL4757155 0.75 NPC1 (0.59) SMN1; SMN2MEN1KMT2AHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2178852-B9 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2016-06-22 EP disclosed
EP-2178852-B1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2015-07-22 EP disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC TOP1 3011/4885SMN1; SMN2 3410/4885MEN1 4564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.